Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Stem cells and patents: a potent mix

June 10, 2010 Research and Development Stem cells, stem cell

In recent years, there has been much debate about whether or not the use of stem cells in medical research …
Feature
Genzyme

Genzyme and Icahn agree compromise deal

June 10, 2010 Research and Development, Sales and Marketing Genzyme

Carl Icahn has won his battle with Genzyme to have his associates given a place on the company’s board.The US …
News
Blog footer

Digital Pharma: Online clinical collaboration

June 10, 2010 Research and Development biomarkers, digital doctors, digital pharma research, proteomic

A new online educational resource will offer researchers across the medical community access to peer-reviewed information on biomarkers. The portal …
News

Pfizer appoints neuroscience research head

June 10, 2010 Research and Development Pfizer, appointment, research and development

Pfizer has appointed Dr Michael Ehlers chief scientific officer for neuroscience research. Dr Ehlers most recently served as the George …
Appointment

‘Stellar’ performance from targeted lung cancer drug

June 9, 2010 Research and Development Pfizer, biomarkers, crizotinib

A new targeted treatment for non small cell lung cancer has produced spectacular results in a sub-group of patients. Pfizer’s …
News

Nerve gas antidote completes phase I trial

June 9, 2010 Research and Development Protalix, biodefence

Israeli biotech firm Protalix has completed a phase I clinical trial for its intravenous nerve gas antidote. The drug is …
News

Eisai’s breast cancer drug impresses at ASCO

June 9, 2010 Research and Development ASCO, Eisai, Xeloda, eribulin

A new cancer drug developed by Japanese pharma company Eisai has shown promise in increasing overall survival rates in heavily …
News

Dr Laurent Audoly joins Pieris

June 9, 2010 Research and Development Pieris, appointment, research and development

French biotech company Pieris has appointed Dr Laurent Audoly as chief scientific officer. Dr Audoly was most recently biologics research …
Appointment

Merck Serono resubmits oral MS therapy to FDA

June 8, 2010 Research and Development Cladribine, MS, Merck KGaA

Merck Serono has re-submitted its oral multiple sclerosis therapy cladribine to US regulators. Merck Serono, a Swiss division of Merck …
News

Sanofi to develop monoclonal antibody jabs

June 8, 2010 Research and Development Sanofi Pasteur, Vivalis, vaccines

Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …
News

EMA under fire for blocking data access

June 8, 2010 Research and Development, Sales and Marketing Acomplia, Alli, EMA, Xenical, data

The European ombudsman has called for the European Medicines Agency to grant access to clinical study reports and trial protocols …
News

Idis appoints Richard Greatorex

June 8, 2010 Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing

Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …
Appointment

Chiltern Achieves Supplementary Accreditation from the Medicines & Healthcare Products Regulatory Agency

June 7, 2010 Research and Development

Dr Brian Sanderson, Medical Director, Chiltern Early Phase, explains, “In November 2007, the MHRA launched a voluntary accreditation scheme for …
News
Press release
Avastin packs

Avastin promising in ovarian cancer

June 7, 2010 Research and Development ASCO, avastin

Roche’s Avastin took a step closer to winning an additional indication after phase III trial data showed the blockbuster cancer …
News

UCB’s Kola joins Astex board

June 5, 2010 Research and Development Astex, UCB, appointment, research and development

Dr Ismail Kola has joined the board of directors at UK biotech company Astex Therapeutics. Astex’s non-executive chairman Peter Fellner …
Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026